InsiderSignal.AI

InsiderSignal.ai

KMTS - Kestra Medical Technologies, Ltd.

Insider Purchase by Cohen Raymond W (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Cohen Raymond W, serving as Dir at Kestra Medical Technologies, Ltd. (KMTS), purchased 10,000 shares at $19.98 per share, for a total transaction value of $199,800.00. Following this transaction, Cohen Raymond W now holds 50,903 shares of KMTS.

This purchase represents a 24.00% increase in Cohen Raymond W's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, March 26, 2026 and publicly disclosed via SEC Form 4 filing on Monday, March 30, 2026, 4 days after the trade was made.

Kestra Medical Technologies, Ltd. operates in the HEALTHCARE sector, specifically within the MEDICAL INSTRUMENTS & SUPPLIES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Cohen Raymond W

Dir

Raymond W. Cohen is a veteran medical technology executive with over 40 years of experience in the life sciences industry, currently serving as an independent director on the board of Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), where he has recently engaged in insider trading activities[[1]](https://www.businesswire.com/news/home/20240725221367/en/Kestra-Medical-Technologies-Announces-Appointment-of-Veteran-Medical-Device-Executive-Raymond-W.-Cohen-to-its-Board-of-Directors)[[2]](https://inspiremd.com/team/raymond-w-cohen/)[[4]](https://nalumed.com/nalu-medical-appoints-veteran-medtech-executive-raymond-w-cohen-chairman-of-its-board-of-directors/). He joined Kestra's board in 2024, bringing expertise in external defibrillation and commercial growth strategies to support the company's ASSURE Wearable Cardioverter Defibrillator[[1]](https://www.businesswire.com/news/home/20240725221367/en/Kestra-Medical-Technologies-Announces-Appointment-of-Veteran-Medical-Device-Executive-Raymond-W.-Cohen-to-its-Board-of-Directors). Cohen holds board positions at multiple medtech firms, including InspireMD, Spectrum Vascular, Nalu Medical (as Chairman), Tulavi (as Vice Chairman), and others[[2]](https://inspiremd.com/team/raymond-w-cohen/)[[3]](https://west.devicetalks.com/speaker/raymond-cohen/)[[4]](https://nalumed.com/nalu-medical-appoints-veteran-medtech-executive-raymond-w-cohen-chairman-of-its-board-of-directors/)[[6]](https://www.bio-beat.com/member/raymond-w-cohen/). Cohen co-founded Axonics, Inc. in 2013, served as CEO, took it public in 2018, and led it to a $3.7 billion acquisition by Boston Scientific in 2024, earning recognitions such as Deloitte Technology Fast 500 top ranking and Financial Times' fastest-growing company in the Americas[[1]](https://www.businesswire.com/news/home/20240725221367/en/Kestra-Medical-Technologies-Announces-Appointment-of-Veteran-Medical-Device-Executive-Raymond-W.-Cohen-to-its-Board-of-Directors)[[2]](https://inspiremd.com/team/raymond-w-cohen/)[[3]](https://west.devicetalks.com/speaker/raymond-cohen/)[[4]](https://nalumed.com/nalu-medical-appoints-veteran-medtech-executive-raymond-w-cohen-chairman-of-its-board-of-directors/). Previously, he was CEO of Vessix Vascular (acquired by Boston Scientific in 2012) and Cardiac Science Inc. (acquired by Zoll Medical), and Chairman of SoniVie Ltd. (acquired by Boston Scientific for $600 million in 2025)[[2]](https://inspiremd.com/team/raymond-w-cohen/)[[3]](https://west.devicetalks.com/speaker/raymond-cohen/)[[4]](https://nalumed.com/nalu-medical-appoints-veteran-medtech-executive-raymond-w-cohen-chairman-of-its-board-of-directors/). Awards include the 2024 MedTech MVP Award, Orange County Business Journal Businessperson of the Year, SoCalBio Lifetime Achievement Award (2021), and Ernst & Young Entrepreneur of the Year (2020)[[1]](https://www.businesswire.com/news/home/20240725221367/en/Kestra-Medical-Technologies-Announces-Appointment-of-Veteran-Medical-Device-Executive-Raymond-W.-Cohen-to-its-Board-of-Directors)[[3]](https://west.devicetalks.com/speaker/raymond-cohen/)[[4]](https://nalumed.com/nalu-medical-appoints-veteran-medtech-executive-raymond-w-cohen-chairman-of-its-board-of-directors/). He holds a B.S. in Business Management from Binghamton University[[3]](https://west.devicetalks.com/speaker/raymond-cohen/).

View full insider profile →

Trade Price

$19.98

Quantity

10,000

Total Value

$199,800.00

Shares Owned

50,903

Trade Date

Thursday, March 26, 2026

9 days ago

SEC Filing Date

Monday, March 30, 2026

Filed 4 days after trade

HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES

About Kestra Medical Technologies, Ltd.

Company Overview

No company information available
View news mentioning KMTS

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5228651

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime